A patient using the breast cancer drug Kadcyla, which could be blocked from routine NHS access because it is too expensive, told ITV News the treatment had improved her quality of life.
"I was in quite a bad state, and within about two cycles my life felt like it had turned a corner. I was able to do things I wasn't able to do prior to being on this treatment," Mani said of the drug, which currently costs around £90,000 per patient.
More top news
The figures by the Global Slavery Index are a third higher than previously thought.
Sara Di Pietrantonio, 22, died in Rome on Sunday.
A vote to remain in the EU will see Brussels exert more power over the NHS, according to the Cabinet minister.